Related Experiment Video
Updated: Aug 18, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
[Lysozyme in children with acute and chronic inflammatory intestinal diseases]
Insights
Fecal lysozyme levels are elevated in children with Rotavirus enteritis and active Crohn's disease or ulcerative colitis. Measuring fecal lysozyme can monitor disease activity and treatment effectiveness in pediatric inflammatory bowel diseases.
Area of Science:
- Gastroenterology
- Biochemistry
- Pediatrics
Context:
- Inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis significantly impact children's health.
- Accurate diagnostic and monitoring tools are crucial for managing pediatric IBD and infectious enteritis.
Purpose:
- To investigate fecal lysozyme excretion as a potential biomarker in pediatric gastroenterological conditions.
- To assess the correlation between fecal lysozyme levels and disease activity in Rotavirus enteritis and IBD.
Summary:
- Fecal lysozyme levels were significantly higher in infants with Rotavirus enteritis compared to healthy controls.
- Elevated fecal lysozyme was observed in untreated Crohn's disease and ulcerative colitis patients.
- Treatment with Salazosulfapyridine, Prednisone, and elemental diet led to a significant decrease in fecal lysozyme levels in IBD patients.
Impact:
- Fecal lysozyme excretion serves as a valuable indicator of clinical disease activity in pediatric gastroenteritis and IBD.
- It can be utilized to monitor therapeutic efficacy and detect relapses in affected children.
- This biomarker aids in objective assessment and management of pediatric gastrointestinal disorders.
Abstract:
Fecal lysozyme excretion was determined in two hundred children and adolescent. In sixty three infants with enteritis due to Rotavirus the fecal lysozyme level was found to be significant higher than in the feces of a group of healthy infants (p less than 0.01). Elevated fecal lysozyme excretion could be detected in patients with untreated Crohn's disease. After treatment with Salazosulfapyridine, Prednisone and elemental diet during six week a significant drop in fecal lysozyme level was observed (p less than 0.01). In eighteen adolescent with Colitis ulcerosa and Crohn's disease the lysozyme level of colonic mucosa was found to be significant higher than a control group (p less than 0.01). The fecal lysozyme excretion can be used as an indicator for the clinical activity of the disease, as a control for therapeutic efficiency and a marker for a relapse.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations